| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.05 | 0.07 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.08 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |